tangeretin has been researched along with Carcinoma, Ductal, Breast in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakshmi, A; Subramanian, S | 1 |
1 other study(ies) available for tangeretin and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; alpha-Fetoproteins; Animals; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Carcinoma, Ductal, Breast; Drug Screening Assays, Antitumor; Female; Flavones; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metabolic Detoxication, Phase I; Mucin-1; Oxidative Stress; Rats; Rats, Wistar; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiobarbituric Acid Reactive Substances; Tumor Burden | 2014 |